StockWatch
·
Misc Health and Biotechnology Services
Quarterly ResultOct 29, 2026, 05:06 PM

DaVita Q3 Net Income $269.4M; EPS $3.40; Revenue $3.58B

AI Summary

DaVita Inc. reported its third-quarter financial results, showing a significant increase in net income and earnings per share compared to the same period last year. Total revenues also saw an increase for both the quarter and the nine-month period. The company recorded goodwill impairment charges and an increase in long-term debt during the period.

Key Highlights

  • DaVita Inc. reported Q3 2026 net income of $269.4M, up from $240.2M in Q3 2025.
  • For the nine months ended Sep 30, 2026, net income was $887.6M, compared to $747.7M in the prior year.
  • Diluted EPS for Q3 2026 was $3.40, up from $2.04 in Q3 2025.
  • Total revenues for Q3 2026 increased to $3.58B from $3.42B in Q3 2025.
  • Nine-month revenues grew to $10.55B from $10.02B year-over-year.
  • Goodwill impairment charges of $62.2M were recorded in the nine months ended Sep 30, 2026.
  • Long-term debt increased to $10.66B as of Sep 30, 2026, from $10.16B as of Dec 31, 2025.